The commodity bull market could create big winners here Weight-loss drugs are creating a new boom in cosmetic treatments. These three aesthetics stocks could benefit as demand continues to grow. By Brian Hunt | September 10, 2026 Read this issue
Longevity spending is poised to explode. One stock to profit from the trend PACCAR hitting all-time highs signals a booming U.S. economy. Senior living stocks are surging across the board. And Eli Lilly's GLP-1 drugs may be the closest thing to longevity medicine we've ever seen. By Brian Hunt | July 27, 2026 Read this issue
Five stocks for investing in an industry about to explode in size GLP-1 drugs are fueling explosive growth in the peptide industry. Learn which companies could benefit as this emerging health care trend expands. By Brian Hunt | June 25, 2026 Read this issue